Malaysia’s overseas healthcare business extends from large private hospitals in Kuala Lumpur to cardiac specialists and fertility centres. Indonesia remains its largest market, but demand from China, Cambodia and other countries is shaping how providers compete.
At Subang Jaya Medical Centre, the effort to attract patients from Cambodia reaches beyond the hospital doors. The hospital offers Khmer interpretation, discusses costs before travel and says it wants to work with Cambodian doctors on cases that need care in both countries. It reports that Cambodian patient numbers rose by more than 50% over the preceding year.
That is a more revealing picture of medical tourism than a hospital lobby lined with national flags. Building an overseas patient business means connecting doctors, explaining bills and making treatment possible for someone whose home may be several flights away.
Malaysia has several versions of that business. Sunway Medical Centre and Prince Court Medical Centre advertise broad international reach. Island Hospital in Penang reports substantial overseas patient activity. Institut Jantung Negara concentrates on heart care. Specialist fertility providers offer another route into international markets.
For patients, these differences help explain which questions to ask before choosing a provider. For hospital operators and referral partners, they show where Malaysia’s next sources of demand may develop.
A growing industry with a strong Indonesian foundation
Malaysia recorded approximately 1.84 million healthcare travellers and RM3.34 billion in healthcare travel revenue in preliminary figures for 2025. The Malaysia Healthcare Travel Council, or MHTC, published those figures in April 2026, based on records available at 31 March. Its corresponding figures for 2024 were approximately 1.59 million travellers and RM2.72 billion in revenue.
Indonesia remains central to that business. In a separate April 2026 release, MHTC attributed 65.8% of Malaysia’s medical tourism revenue to Indonesian patients. In northern Malaysia, their contribution was nearly 90%. These are revenue shares across the country and region, rather than patient shares or figures for individual hospitals.
The established connection between Medan and Penang helps explain the northern concentration. MHTC describes a healthcare travel route serving families from North Sumatra and surrounding areas, supported by services tailored to Indonesian patients. For those families, familiarity with a destination and its hospitals can matter alongside the treatment itself.
A hospital does not become less international because many of its patients come from a neighbouring country. The business question is whether it also attracts sustained demand elsewhere. The patient question is whether its teams can provide the particular care and support someone needs.
The hospitals behind Malaysia’s international healthcare business
The following profiles cover different roles in the market, rather than a ranking of medical quality. Published patient figures are attributed to their sources. Where comparable overseas volumes are unavailable, the profiles focus on documented services and clinical scope.
Sunway Medical Centre, Sunway City: a broad specialist hospital serving several markets
Location: Sunway City, Selangor, in Greater Kuala Lumpur.
Sunway combines a wide range of hospital services with a dedicated international patient operation. Its website lists cancer care, neuroscience, heart and lung care, bone and joint services, digestive health, and women’s and children’s services. That breadth matters when a patient needs several specialists involved in diagnosis or treatment.
The hospital reports more than 146,000 international patient visits from 164 nationalities “to date.” It also says thousands travel there annually from Indonesia, China, Indochina, Singapore and elsewhere. The cumulative visit figure has no defined reporting period and should not be described as an annual count of individual medical tourists.
Its international patient centre arranges appointments and teleconsultations, supports translation, and helps with transport and visa extensions. It also works with international insurers and claims administrators, with cashless treatment available to eligible patients.
Sunway’s role is that of a broad treatment destination: a place where overseas families can organise care across several departments. Patients should establish which specialists will review their case before making travel commitments.
Prince Court Medical Centre: international reach from central Kuala Lumpur
Location: Kuala Lumpur.
Prince Court reports having served patients from more than 140 countries. Its international patient page describes a hospital with more than 160 consultants and directs visitors to international insurance information, hotel partners and dedicated China and Indonesia pages.
The attraction of this model is the ability to organise a hospital visit alongside the practical needs of staying in the capital. For a family travelling with a patient, accommodation, appointments and payment arrangements are all part of the same decision.
Prince Court also advises overseas patients to allow time for recovery and possible delays. That is a useful reminder that a treatment trip cannot always be organised around a fixed return flight. Its guidance asks patients to build flexibility into the stay.
The 140-country figure establishes claimed geographical breadth, but the page gives no reporting period or annual country breakdown. It supports Prince Court’s inclusion among hospitals with an international patient base; it does not show how much business comes from any particular country.
Island Hospital: Penang’s large overseas patient operation
Location: Penang.
Island Hospital provides one of the clearest dated statements of international activity. In December 2025, owner IHH Healthcare said the hospital had treated about 700,000 international patients since 2022, from more than 80 countries. The announcement also highlighted patients from over 100 cities in Indonesia. It did not explain how repeat attendances were counted.
The hospital’s services include cardiology, oncology, orthopaedics, gastroenterology and neurology, supported by more than 120 specialists, according to the same release. It also describes support from pre-arrival coordination through follow-up care.
Island was named the winner of Malaysia’s first Flagship Medical Tourism Hospital programme in December 2025. IHH said the assessment covered clinical quality, patient safety, patient experience, innovation and operational performance.
Its position illustrates Penang’s combination of a deep Indonesian patient network and wider international reach. Neither has to displace the other. For referral partners, the next useful detail would be the hospital’s annual overseas activity by treatment and country.
Subang Jaya Medical Centre: building treatment relationships with Cambodia
Location: Subang Jaya, Selangor.
SJMC’s Cambodian activity offers a closer view of how an additional source market develops. In an interview republished on the hospital’s website, management linked rising Cambodian demand particularly to cancer and heart care. The account describes Khmer interpreters, financial counselling and cooperation with doctors in Cambodia.
“We believe in working alongside Cambodian doctors, not competing with them,” Bryan Lin said in the published interview.
Lin, identified in the interview as SJMC’s chief executive and a regional chief executive at Asia OneHealthcare, also discussed joint case management and continuity after patients return home.
The hospital’s international patient service covers a broad clinical offering, including adult and children’s oncology, heart surgery, neurology, orthopaedics and gastroenterology. It publishes information on hotel arrangements and airport transfers, subject to conditions.
The commercial lesson is specific: a referral relationship can continue after discharge. When overseas and local teams cooperate, a patient does not have to treat each appointment as an isolated encounter in another country.
Mahkota Medical Centre: a substantial international operation in Melaka
Location: Melaka.
Mahkota reports more than 95,000 international patients annually. Founded in 1994, the hospital is part of HMI Group and describes a 305-bed facility with more than 47 specialties. Its services include diagnostic, therapeutic and intensive care facilities.
Those figures place Melaka firmly in the discussion of Malaysia’s healthcare travel business, alongside the capital and Penang. Mahkota was also among the finalists in the Flagship Medical Tourism Hospital programme.
For families considering treatment, its location creates a different travel plan from a stay in Kuala Lumpur. The useful comparison is the complete arrangement: the relevant specialist, the hospital stay, accommodation for companions and the journey between appointments.
Mahkota’s website does not accompany its annual international patient figure with a country breakdown or an explanation of repeat visits. The figure demonstrates the scale it reports, while leaving the composition of that business open. A strong Indonesian patient base would not, by itself, justify excluding it from an international hospital shortlist.
Institut Jantung Negara: a specialist route into international heart care
Location: Kuala Lumpur.
Institut Jantung Negara, usually known as IJN, brings a different proposition. Established in 1992, Malaysia’s National Heart Institute focuses on cardiovascular and thoracic care for adults and children. Its relevance to an overseas patient begins with the heart condition requiring assessment.
IJN’s international patient service describes a process that starts with submitting medical reports for specialist review. Patients then receive treatment recommendations and estimated costs before assistance with appointments, travel and accommodation. Multilingual support is also listed.
That sequence is particularly useful for someone deciding whether a journey is necessary. A specialist review before departure gives the patient a basis for discussing the proposed treatment with their doctor at home.
IJN was another finalist in Malaysia’s flagship programme. The sources reviewed for this article did not establish a reliable annual country-by-country total for overseas patients. Its profile rests on its defined clinical focus and documented international service, rather than an unsupported estimate of foreign patient volume.
Gleneagles and Pantai Kuala Lumpur: two hospitals within a wider network
Locations: Jalan Ampang and Bukit Pantai, Kuala Lumpur.
Gleneagles Hospital Kuala Lumpur and Pantai Hospital Kuala Lumpur are separate hospitals within IHH Healthcare. They add established general and specialist hospital capacity to the capital’s international offering.
Gleneagles describes a 376-bed hospital serving local and international patients. Its overseas patient guidance addresses appointment booking, medical documents and arrival arrangements. These details are useful for travellers deciding how to organise their first visit.
Pantai Kuala Lumpur, established in 1974, reports more than 500 licensed beds and over 200 consultants. Its published services include cancer care, robotic surgery and congenital heart services, alongside a dedicated route for international enquiries.
Group ownership can be useful context, but patients still need to compare the individual hospital and treating team. The pages reviewed do not provide comparable annual overseas patient totals for these two facilities. They belong in the discussion because of their documented international services, without assigning them an unverified place in a volume ranking.
Beyond general hospitals: what fertility care reveals about demand
A specialist provider can offer clearer evidence of a particular overseas market than a large hospital’s country count.
Alpha IVF Group illustrates the point. In its second-quarter FY2025 investor briefing, held in January 2025, the fertility group reported RM8.1 million in revenue from China, a fourfold increase. Indonesian patients remained its largest revenue source.
This is an older group-level financial disclosure, not an annual patient count for a single Malaysian centre. Even so, it establishes a commercial contribution from a named market beyond Indonesia.
For operators, the distinction is useful. A country appearing in a patient database says someone from that country received care. Revenue by market shows more about the size of the business. Neither measure establishes clinical success, and fertility patients still need treatment-specific information relevant to their circumstances.
China’s growth gives hospitals a reason to widen their reach
MHTC reported that healthcare travel revenue from China exceeded RM200 million in 2025. In the first quarter of 2026, revenue from the market rose 23% year on year, while healthcare traveller volume increased 17%.
“China remains one of Malaysia Healthcare’s most significant and fastest-growing source markets,” MHTC chief executive Suriaghandi Suppiah said in a July 2026 statement.
The statement accompanied a healthcare promotion programme in Shenzhen involving engagement with facilitators, referral partners, insurers and other industry participants. MHTC is the industry’s promotion body, so its account should be read with that role in mind.
Together with SJMC’s Cambodian activity, these disclosures suggest that Malaysia’s expansion is taking place through specific treatment markets and professional relationships. The work includes explaining a clinical service, helping a referring doctor assess a case and making the financial arrangements understandable.
There is an operational choice behind every new market. Hospitals need to decide which languages to support, which referring organisations to work with and how much coordination a patient will need after leaving Malaysia. Advertising can start a conversation; the service has to sustain it.
How to read the international patient numbers
The available figures show substantial overseas activity, but they should not be placed in a single league table. Sunway reports cumulative visits without a defined period. Island’s figure covers the years since 2022. Mahkota describes an annual count. Prince Court gives a country total.
Three distinctions make the data easier to use:
- Patients and visits: one person may attend several appointments or return for further treatment. A visit count is not necessarily a count of different people.
- Nationality and residence: a foreign national may already live in Malaysia. Country of residence and the purpose of travel help identify people arriving specifically for care.
- Hospital and group: revenue earned across several facilities cannot be assigned to one hospital without supporting information.
For referral partners, a practical request is an annual breakdown of overseas patients by country of residence, with repeat visits separate. For families, those figures are background. The more immediate question is how often the proposed team handles their condition and what outcomes it can document.
What patients should establish before booking treatment
An international patient office can make travel and appointments easier. Clinical decisions still require a conversation with the treating team.
The US Centers for Disease Control and Prevention advises medical travellers to assess both the facility and the healthcare professional. Its Yellow Book guidance also states that accreditation does not guarantee a good outcome. It stresses the importance of understanding follow-up arrangements and costs, and obtaining medical records before returning home.
Get the clinical plan before the travel plan
Ask who will review the medical records, which doctor will take responsibility for treatment and whether further tests could change the recommendation. The first reply from an enquiry team should lead to a clinical assessment, not simply a package booking.
Ask for a written estimate with clear exclusions
A quoted procedure price may not describe the full episode of care. Ask what the estimate includes, what could increase the bill and how additional treatment would be authorised. Request clarification about follow-up charges and insurance approval before committing to a trip.
Agree on aftercare across both countries
Ask how the treating team will communicate with the doctor at home. Establish who receives the discharge summary, how questions will be handled and what to do if recovery does not follow the expected course. A video appointment may be useful, but the plan should also explain when an in-person assessment is needed.
The next stage for Malaysia will be built around treatment relationships
Malaysia’s international hospital business has room for several models: broad specialist hospitals, centres built around a particular discipline, and providers with longstanding ties to nearby countries. The evidence from China and Cambodia shows why some are investing in additional markets.
For those investments to last, the connection cannot end at discharge. A referring doctor needs usable records. A family needs a bill it understands. A patient needs to know which team remains responsible for which part of their care.
That is where the next overseas referral can be earned: when a doctor at home receives a clear treatment summary, can reach the Malaysian specialist and feels confident sending another patient.
